Justin A Ezekowitz is an expert in Cardiology at University of Alberta (Canada). As of October 2026, ScienceLeadR ranks Justin A Ezekowitz in the top 1% of experts worldwide for Heart Failure and Diabetes Mellitus, and in the top 1% of experts in Canada for Cardiac Output, Low. Justin A Ezekowitz has authored 694 publications, the most recent in 2028, and is an investigator in 38 clinical trials. SLR score: 2,711 (community average: 125). How the SLR is computed.

LeadR Profile

Justin A Ezekowitz University of Alberta Canada
2 711 ScienceLeadR Reputation 2711
Network Map

Cardiology

Subspecialties: Public Health - Endocrinology - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2002 - 2028

Source: PubMed

University of Alberta

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 694

Citations

Citations: 59 827 1st author: 52 Last author: 123 Unique author: 17


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Prognostic Significance and Factors Associated With Worsening LV Dilatation in Heart Failure.
PMID 42841707 — mortality, hospitalization, heart failure, heart, cardiology
Clin Cardiol20260
MAGGIC and PREDICT-HF Models in the VICTOR Trial: Do Traditional Risk Scores Still Work in Well-Treated Ambulatory Patients with HFrEF?
PMID 42766804 — heart failure, work, heart failure, systolic
Eur J Heart Fail20260
Automated assessment of echocardiograms to aid diagnosis of heart failure with preserved ejection fraction.
PMID 42756927 — research design, heart failure, heart, heart failure, diastolic, deep learning, diagnosis, learning
Eur Heart J Digit Health20260
Mortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial analyses of the VICTOR trial.
PMID 42748047 — mortality, disease-free survival, heart failure, probability, heart failure, systolic, actuarial analysis
Eur J Heart Fail20260
Efficacy of Vericiguat by Background Guideline-Directed Medical Therapy in the VICTOR Trial.
PMID 42706896 — hospitalization, heart failure, heart failure, systolic, therapeutics
Eur J Heart Fail20260

Clinical Studies 38

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 16
N/A 13
Phase 2 6
Phase 4 2
Phase 1/Phase 2 1

By status:

Completed 29
Terminated 5
Unknown 2
Active not recruiting 1
Recruiting 1

By type:

Interventional 35
Observational 3

By Monocentric/Multicentric:

monocentric 10
multicentric2to4 3
multicentric5to9 1
multicentricup10 24

Main Topics

Cohort/Consortium Investigators 2

LeadR Networks

Main global connection map